Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloserine in the Treatment of Sleep Apnea
NCT02735694Phase 1Terminated
- Sponsor
- University of Manitoba
- Start
- Sep 2015
- Primary completion
- Jun 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of d-cycloserine in sleep apnea syndrome (SAS) (2 arms), sponsored by University of Manitoba. Primary endpoint: Apnea-hypopnea index at 1 week. Started Sep 2015; status: terminated.
02
Drugs
d-cycloserine
03
Conditions
sleep apnea syndrome (SAS)
Beyond the preview
Go deeper on NCT02735694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735694.